Skip to main navigation Skip to search Skip to main content

Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines

  • Noam Van Der Walde
  • , Reshma Jagsi
  • , Efrat Dotan
  • , Joel Baumgartner
  • , Ilene S. Browner
  • , Peggy Burhenn
  • , Harvey Jay Cohen
  • , Barish H. Edil
  • , Beatrice Edwards
  • , Martine Extermann
  • , Apar Kishor P. Ganti
  • , Cary Gross
  • , Joleen Hubbard
  • , Nancy L. Keating
  • , Beatriz Korc-Grodzicki
  • , June M. McKoy
  • , Bruno C. Medeiros
  • , Ewa Mrozek
  • , Tracey O'Connor
  • , Hope S. Rugo
  • Randall W. Rupper, Dale Shepard, Rebecca A. Silliman, Derek L. Stirewalt, William P. Tew, Louise C. Walter, Tanya Wildes, Mary Anne Bergman, Hema Sundar, Arti Hurria
  • University of Tennessee Health Science Center
  • University of Michigan, Ann Arbor
  • University of California at San Diego
  • Johns Hopkins University
  • City of Hope National Medical Center
  • Duke University
  • University of Colorado
  • University of Texas MD Anderson Cancer Center
  • University of South Florida
  • University of Nebraska Medical Center
  • Yale University
  • Mayo Clinic
  • Dana-Farber/Brigham and Women's Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Northwestern University
  • Stanford University
  • Ohio State University
  • Roswell Park Cancer Institute
  • University of California at San Francisco
  • University of Utah
  • Case Western Reserve University
  • Seattle Cancer Care Alliance
  • Washington University St. Louis
  • National Comprehensive Cancer Network

Research output: Contribution to journal › Review article › peer-review

91 Scopus citations

Abstract

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.

Original languageEnglish
Pages (from-to)1357-1370
Number of pages14
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume14
Issue number11
DOIs
StatePublished - Nov 1 2016

Keywords

  • Aged
  • Aged, 80 and over
  • Humans
  • Medical Oncology

Fingerprint

Dive into the research topics of 'Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this